Search

everythinglearnresearchcommunity

for

Search:↓

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

People with certain skin diseases often have more trouble understanding and describing their emotions, which can affect their health and treatment results.

People with trichotillomania or skin picking disorder generally sleep worse than those without these conditions.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Managing diabetes can lead to eating disorders, and eating disorders can make diabetes harder to control.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Patients with non-scarring alopecia often experience emotional disorders like depression and stress.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Melatonin helps hair grow by activating the RORα receptor in goats.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Patients with non-scarring hair loss often have emotional disorders.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Women are more likely to have long-term post-COVID symptoms than men.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.